Not finding it? Sign in to also search OpenAlex live.
-
Long-Term Outcomes of Increased Versus Conventional Adalimumab Dose Interval for Patients With Crohn’s Disease in Stable Remission: 3-Year Follow-Up of the Randomized Controlled LADI Trial
Lisa M.A. van Lierop, C. Janneke van der Woude, Frank Hoentjen, Annemarie Charlotte de Vries, Nathan den Broeder, Alexander G L Bodelier, +6 more
2citations -
Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection2022 Journal of Personalized Medicine article Medicine Autoimmune and Inflammatory Disorders Open access
Marcella Ricardis May, Albert Rübben, Andrea Lennertz, Luk Vanstreels, Marike M. Leijs
2citations -
Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients2022 Frontiers in Immunology article Biochemistry, Genetics and Molecular Biology Diabetes and associated disorders Open access
Tatjana Nikolić, Jessica S. Suwandi, Joris Wesselius, Sandra Laban, Antoinette M. Joosten, Petra Sonneveld, +5 more
51citations -
Eicosapentaenoic acid induces an anti-inflammatory transcriptomic landscape in T cells implicating a pathway independent of triglyceride lowering in cardiovascular risk reduction2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Nursing Fatty Acid Research and Health Open access
Nathalie A. Reilly, Koen F. Dekkers, Jeroen Molenaar, Sinthuja Arumugam, Thomas B. Kuipers, Yavuz Ariyürek, +3 more
0citations -
P191 Efficacy and improvement in patient-reported outcomes at weeks 16 and 52 in ixekizumab treated biological naïve patients with radiographic axial spondyloarthritis achieving clinically important pain at night reduction at week 16: results from COAST-V trial
Sofía Ramiro, Cédric Lukas, Michael John Nissen, Yves Schymura, Khai Jing Ng, Gabriel Doridot, +3 more
0citations -
Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing2025 International Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Sofía L. J. Peeters, Didier Meulendijks, Zerina Kadric, Sara Ibrovic, Geert‐Jan Creemers, Vanja Milosevic, +7 more
7citations -
Safety and pharmacokinetic analysis of UGT1A1 genotype-guided dosing of irinotecan.2021 Journal of Clinical Oncology conference-abstract Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism
Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert‐Jan Creemers, Birgit A. L. M. Deiman, Jesse Joachim Swen, +9 more
4citations -
A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS Perspective2025 The Journal of Clinical Pharmacology review Medicine Renal cell carcinoma treatment Open access
Zhiyuan Tan, Swantje Völler, Aymara Sancho‐Araiz, Catherijne A. J. Knibbe, Dirk Jan A. R. Moes
3citations -
Functionality of a next generation biosynthetic bacterial 6-phytase in enhancing phosphorus availability to broilers fed a corn-soybean meal-based diet2020 Animal Feed Science and Technology article Agricultural and Biological Sciences Phytase and its Applications Open access
Yueming Dersjant-Li, Gregory S. Archer, Austin M. Stiewert, A.A. Brown, Eric B. Sobotik, Austin Jasek, +12 more
37citations -
Enhancing synchrotron radiation micro-CT images using deep learning: an application of Noise2Inverse on bone imaging2025 Journal of Synchrotron Radiation article Computer Science Image and Signal Denoising Methods Open access
Yoshihiro Obata, Dilworth Y. Parkinson, Daniël M. Pelt, Claire Acevedo
4citations -
Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy2024 Clinical Pharmacology & Therapeutics article Medicine Antibiotics Pharmacokinetics and Efficacy Open access
Emiel Leegwater, Lauren Baidjoe, Erik B. Wilms, Leo G. Visser, Daan Johannes Touw, Brenda C. M. de Winter, +6 more
12citations -
PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma2025 Journal of Hematology & Oncology article Medicine CNS Lymphoma Diagnosis and Treatment Open access
Vanja Zeremski, Tobias Ronny Haage, Hanno Maximilian Witte, Louisa Adolph, Sina Alexandra Beer, Gerhard Behre, +10 more
4citations -
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele2026 JCO Precision Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Niels Heersche, Jonathan Emanuel Knikman, Maarten J. Deenen, Hilde Rosing, Ron H. N. van Schaik, Jos H. Beijnen, +7 more
2citations -
Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy2025 Clinical Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access
Jincan Zan, Jingyi Li, Muh Geot Wong, Dana Kim, Sufang Shi, Helen Monaghan, +3 more
9citations -
Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017–2024): a retrospective, multicentre cohort study2026 The Lancet Regional Health - Europe article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Sofía L. J. Peeters, Niels Heersche, Doortje T.M.M. Böhm, Stefan Böhringer, Roselien Guiljam, Emma C. Hulshof, +17 more
3citations -
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients2023 Clinical Pharmacokinetics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Ruben A.G. van Eerden, Nikki S. IJzerman, Milan van Meekeren, Esther Oomen‐de Hoop, Niels A.D. Guchelaar, Andrea M. W. Visser, +10 more
10citations -
NP-012 Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan: a multicentre real-world study2026 European Journal of Hospital Pharmacy conference-abstract Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism
Sofía L. J. Peeters, Niels Heersche, Doortje T.M.M. Böhm, S. Böhringer, Roselien Guiljam, Marije Joosse, +14 more
0citations -
The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients2023 European Journal of Clinical Pharmacology article Medicine Venous Thromboembolism Diagnosis and Management Open access
Logan E. Mast, Mariska Y. M. Peeters, Maaike Söhne, C. M. Hackeng, Catherijne A. J. Knibbe, Marcel P. H. van den Broek
1citations -
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients2022 European Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert‐Jan Creemers, Birgit A. L. M. Deiman, Jesse Joachim Swen, +15 more
57citations